SUBSCRIBE Blog with us: BLOGbiotech

GEN News Highlights

• Email
• Print
• Share
• More GEN News Highlights

Jul 30 2009, 10:51 AM EST

Covance Takes Over Merck & Co.’s Gene-Expression Lab and Gains $145M Contract

GEN News Highlights

Merck & Co. will pay $145 million over five years to purchase genomic analysis services from Covance. Additionally, Covance will acquire Merck's Seattle-based gene-expression laboratory, which offers genotyping, gene sequencing, and gene-expression profiling.

“We recognized the need to expand our footprint in the important and growing genomics testing market and this transaction provided both a superior and quicker entry point than the build or buy options we considered,” notes Joe Herring, chairman and CEO of Covance.

Covance expects to offer employment to a majority of current Merck employees and is scheduled to assume occupancy and operation of the lab on August 17. Covance has headquarters in Princeton, NJ, and reports that it has annual revenues of more than $1.7 billion.

 

♦♦♦
Related News
Covance Purchases Equity Stake in Caprion Proteomics (Dec. 17, 2008)
Covance Takes Over Lilly’s Greenfield, Indiana Site for $50M and Gains $1.6B Contract (Aug. 6, 2008)
Covance to Divest Cardiac Safety Services to eResearchTechnology for $35M (Nov. 28, 2007)
Covance will Expand Manufacturing Operations in Virginia (Nov. 21, 2007)

• Email
• Print
• Share
• More GEN News Highlights

Comment on this News:

Name:
Title:
Comment:
	HELP US FIGHT SPAMMING ROBOTS by answering the following simple question. It will verify you as a legitimate user wishing to post a comment. Thank you for your cooperation.

CAREER CENTER

WEBINARS

PODCASTS

MOST POPULAR